Eli Lilly & Co. agreed to buy gene-editing biotech company Verve Therapeutics Inc. for $1.3 billion, the obesity drugmaker’s ...

Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, sending ...

Eli Lilly and Co. is shelling out $1 billion to buy a Boston biotech known for genetic medicines for cardiovascular disease.

Top oil chief executives have raised the alarm over Israel and Iran’s escalating... Turnover at the Irish arm of the telecommunication company Nokia dropped almost 10... The head of Renault’s budget ...

Yum Brands, the parent firm of KFC, has named Chris Turner, the company’s chief... Kraft Heinz said on Tuesday it would not launch products with artificial colours ...

U.S. stock index futures on Tuesday slipped, as market participants remained on edge amid Israel and Iran's conflict. Here ...